<DOC>
	<DOCNO>NCT00002670</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know whether radiation therapy plus cisplatin effective radiation therapy alone treat patient head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy plus cisplatin radiation therapy alone treat patient head neck cancer remove surgery .</brief_summary>
	<brief_title>Radiation Therapy With Without Chemotherapy Treating Patients With Head Neck Cancer That Has Been Removed During Surgery</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate locoregional control rate , pattern first failure , overall disease-free survival patient advance squamous cell carcinoma head neck high risk locoregional recurrence treat postoperatively concurrent cisplatin radiotherapy . II . Compare toxicity concurrent chemoradiotherapy vs. radiotherapy alone postoperative setting . OUTLINE : Randomized study . Arm I : Radiotherapy . Involved-field irradiation use Co60 , 1-6 MV photon , electron . Arm II : Radiotherapy plus Single-Agent Chemotherapy . Irradiation Arm I ; plus Cisplatin , CDDP , NSC-119875 . PROJECTED ACCRUAL : 438 patient enter approximately 5 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven squamous cell carcinoma one follow site : Hypopharynx Larynx Oral cavity Oropharynx At least 1 follow highrisk factor require : Histologic extracapsular nodal extension Histologic involvement 2 regional lymph node Microscopically positive mucosal margin Complete resection visible palpable disease Therapy must begin within 8 week tumorrelated surgery Bilateral resection may may perform simultaneously Eligibility window begin first definitive surgery Neck dissection require T4 N0 , truly midline supraglottic tumor No tumor lip , nasopharynx , sinuses No synchronous concurrent head neck tumors No evidence distant metastasis Concurrent registration Fixed Tumor Repository Study allow PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60 % 100 % Hematopoietic : WBC least 3,500 Platelets least 100,000 Hepatic : Not specify Renal : Creatinine clearance great 50 mL/min Other : No medical contraindication protocol therapy No second malignancy within 5 year No pregnant nursing woman PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy head neck region Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>